The Company’s headquarters are located at 60 First Street, Cambridge, MA 02141. The main office phone number is 617-465-0013.
Prime Medicine is traded on the NASDAQ Global Market under the ticker symbol PRME and its CUSIP number is 74168J 101.
Prime Medicine was founded in 2019.
The Company’s fiscal year ends on December 31st.
Prime Medicine’s shares began trading on the NASDAQ Global Market in October 2022.
Prime Medicines' transfer agent is Computershare Trust Company, N.A.
Shares can be purchased through a stockbroker of your choice.
Prime Medicine does not currently offer a dividend reinvestment program and does not expect to declare or pay cash or other dividends in our common stock in the foreseeable future.
Goodwin Procter LLP
100 Northern Avenue
Boston, MA 02210
(617) 570-1000
PricewaterhouseCoopers, LLP
1 Broadway, 14th Floor
Cambridge, MA 02142
(617) 530-5000
Prime Medicine’s press release archives can be accessed here.
Prime Medicine’s SEC filings can be accessed here or at www.sec.gov.
Prime Medicine’s annual report and Form 10K can be accessed here or at www.sec.gov.
Additional queries can be directed to Hannah Deresiewicz at hannah.deresiewicz@sternir.com.